Polu Krishna R

Chief Medical Officer at RAPTOR PHARMACEUTICALS CORP. · on record since Jan 20, 2015
Director at Frazier Lifesciences Acquisition Corp · on record since Dec 17, 2020
Chief Medical Officer at Equillium, Inc. · on record since Oct 11, 2018

Insider trading activity of Polu Krishna R

Transactions on record: 14; since Jan 20, 2015

Open-market buys: 0

Open-market sells: 0

Companies traded: 3; last filing Nov 23, 2022

Figures computed from official regulatory filings — .

Companies where Polu Krishna R has traded

Frazier Lifesciences Acquisition Corp1 tx · Nov 23, 2022
Equillium, Inc.8 tx · Apr 24, 2020
RAPTOR PHARMACEUTICALS CORP.5 tx · $214K · Oct 26, 2016

Track record of Polu Krishna R

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Polu Krishna R

Co-insiders of Polu Krishna R

Anderson RaymondRAPTOR PHARMACEUTICALS CORP.
Baltera Robert Jr.Frazier Lifesciences Acquisition Corp
BIGHAM MICHAELFrazier Lifesciences Acquisition Corp
Biocon SAEquillium, Inc.
BRADBURY DANIELEquillium, Inc.
Bruhn Suzanne LouiseRAPTOR PHARMACEUTICALS CORP.
Colabuono PeterEquillium, Inc.
Connelly StephenEquillium, Inc.
Daley Thomas ERAPTOR PHARMACEUTICALS CORP.
DEMSKI MARTHA JEquillium, Inc.
Doude van Troostwijk Henk JRAPTOR PHARMACEUTICALS CORP.
Empey GordonFrazier Lifesciences Acquisition Corp
Erbez GeorgiaRAPTOR PHARMACEUTICALS CORP.
FHMLS X, L.L.C.Frazier Lifesciences Acquisition Corp
FHMLS X, L.P.Frazier Lifesciences Acquisition Corp
FRANKLIN RICHARD LRAPTOR PHARMACEUTICALS CORP.
Frazier Lifesciences Sponsor LLCFrazier Lifesciences Acquisition Corp
Frazier Life Sciences X, L.P.Frazier Lifesciences Acquisition Corp

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Frazier Lifesciences Acquisition CorpListing unverified	Nov 23, 2022	ExerciseD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	OtherD (derivative)	-208,216	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	AwardD (derivative)	208,216	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	AwardD (derivative)	90,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	AwardD (derivative)	125,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	OtherD (derivative)	-90,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Dec 12, 2019	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Equillium, Inc.Listing on record	Feb 15, 2019	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Oct 26, 2016	Other	-23,781	9.00 USD	$214K	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Oct 26, 2016	OtherD (derivative)	-89,152	—	n/a (No price was disclosed in the filing)	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Feb 11, 2016	AwardD (derivative)	89,152	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Feb 11, 2016	Award	23,781	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Jan 20, 2015	AwardD (derivative)	165,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Frazier Lifesciences Acquisition CorpListing unverified	Nov 23, 2022	ExerciseD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	OtherD (derivative)	-208,216	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	AwardD (derivative)	208,216	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	AwardD (derivative)	90,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	AwardD (derivative)	125,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Apr 24, 2020	OtherD (derivative)	-90,000	—	n/a (No price was disclosed in the filing)	SEC
Equillium, Inc.Listing on record	Dec 12, 2019	AwardD (derivative)	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Equillium, Inc.Listing on record	Feb 15, 2019	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Oct 26, 2016	Other	-23,781	9.00 USD	$214K	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Oct 26, 2016	OtherD (derivative)	-89,152	—	n/a (No price was disclosed in the filing)	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Feb 11, 2016	AwardD (derivative)	89,152	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Feb 11, 2016	Award	23,781	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
RAPTOR PHARMACEUTICALS CORP.Listing unverified	Jan 20, 2015	AwardD (derivative)	165,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC